DrugChatter: What’s the timeline for canakinumab biosimilars?
When can canakinumab biosimilars enter the market? Canakinumab (Ilaris) is protected by a web of patents and exclusivity… https://www.Drugchatter.com/chat/53404/what’s-the-timeline-for-canakinumab-biosimilars/
DrugChatter: What’s the timeline for canakinumab biosimilars? Read Post »
